Dongwha, Chong Kun Dang grow fast in generic drug market

Published: 2011-07-14 07:00:00

Updated: 2011-07-14 07:00:00

With Korean pharmaceutical companies struggling to boost up their sluggish sales in the domestic ethical market, Dongwha Pharmaceutical is leading any others, with its sales growth exceeding 19 percent in the first quarter, according to industry sources.

Dongwha's strong push for the local dr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK